Department of Medicine, University of Hong Kong, Queen Mary Hospital, Hong Kong, China.
Palliative Medical Unit, Grantham Hospital, Hong Kong, China.
Ann Palliat Med. 2024 May;13(3):654-660. doi: 10.21037/apm-23-413. Epub 2024 May 14.
Kidney transplantation is the best renal replacement therapy for patients with end stage kidney disease. It provides longer patient survival and better quality of life than dialysis. The clinical course after kidney transplantation could be complex and variable. Patients may develop various complications or even kidney graft failure. Symptom burden related to uraemia in patients with graft failure, and the side-effects of immunosuppression, cause psychological distress and adversely affect the quality of life of patients. Treatment decisions in patients with graft failure can be challenging to patients and their caregivers. Renal palliative care is an emerging field, but its adoption remains relatively low among kidney transplant recipients with progressive graft failure. In this context, timely consideration and referral for palliative care can improve symptom burden, reduce stress in patients and their caregivers, and facilitate treatment goal setting and advanced care planning. Common barriers to bring palliative care to suitable patients include: (I) misconception in patients, caregivers and healthcare providers that palliative care means abandonment of life sustaining treatment; (II) over-optimistic prognostic assessment and over-aggressive management approach; (III) insufficient awareness and training in palliative care of healthcare professionals; (IV) inadequate access to and insufficient resources in palliative care. Enhanced training and awareness, and further studies, would be needed to optimize the decision process and delineate the benefit of palliative care, and to guide evidence-based practice in the transplant population.
肾移植是终末期肾病患者的最佳肾脏替代疗法。与透析相比,它能提供更长的患者生存时间和更好的生活质量。肾移植后的临床过程可能是复杂和多变的。患者可能会出现各种并发症,甚至移植肾失功。移植肾失功患者的尿毒症相关症状负担以及免疫抑制剂的副作用会导致心理困扰,从而对患者的生活质量产生不利影响。移植肾失功患者的治疗决策对患者及其照护者来说具有挑战性。肾脏姑息治疗是一个新兴领域,但在进展性移植肾失功的肾移植受者中,其应用仍然相对较低。在这种情况下,及时考虑并转介姑息治疗可以改善症状负担,减轻患者及其照护者的压力,并有助于确定治疗目标和进行先进的护理计划。将姑息治疗带给合适患者的常见障碍包括:(I)患者、照护者和医疗保健提供者对姑息治疗意味着放弃维持生命的治疗存在误解;(II)过于乐观的预后评估和过于积极的管理方法;(III)医疗保健专业人员对姑息治疗的认识和培训不足;(IV)姑息治疗的可及性不足和资源不足。需要加强培训和提高认识,并进一步研究,以优化决策过程,阐明姑息治疗的益处,并指导移植人群的循证实践。